recombinant DNA technology
英
美 [rɪˈkɑmbɪnənt ˌdiː en ˈeɪ tekˈnɑːlədʒi]
网络 DNA重组技术; 技术; 重组DNA技术; 重组; 重组 DNA技术
双语例句
- Recombinant DNA technology, transgenic technology is also a matter of fact in the molecular level to create the mosaic.
重组DNA技术、转基因技术事实上也都是在制造分子层次上的嵌合体。 - Biochip technology is a great breakthrough of life science after recombinant DNA technology and polymerase chain reaction.
生物芯片技术是继基因工程（重组DNA技术）、聚合酶链式反应（PCR）之后在分子生物学领域中的又一重大突破。 - Certain APIs of low molecular weight, such as antibiotics, amino acids, vitamins, and carbohydrates, can also be produced by recombinant DNA technology.
有些低分子量的原料药，如抗生素、氨基酸、维生素和糖类也可以用重组DNA来生产。 - As recombinant DNA technology is consummating increasingly, genetic engineering drug is frequently researched and utilized.
随着重组DNA技术的不断完善，基因工程药物的研制和利用日益增多。 - This highly interdisciplinary field is closely associated with both the physical and chemical properties of organic and inorganic nanoparticles, as well as to the various aspects of molecular cloning recombinant DNA and protein technology, and immune-ology.
这种新颖的交叉跨度很高的化学学科与有机／无机纳米粒子的物理化学性质，以及分子克隆，DNA重组，蛋白质技术和免疫学有着非常紧密的联系。 - Therapeutic recombinant proteins are produced by the recombinant DNA technology.
重组药用蛋白质是指利用DNA重组技术生产的蛋白质。 - With the development of recombinant DNA and peptide synthesize technology, and advantage in analytical separation technology, more and more proteins and peptides, such as enzyme, activators and inhibitors, poly-and monoclonal antibodies, and various vaccines, are used as pharmaceuticals in clinic.
随着重组DNA和多肽合成技术的发展，更加之分析分离技术的提高，越来越多的蛋白质和多肽，象酶、活性因子、抑制因子、多克隆与单克隆抗体、疫苗，被作为药物应用于临床。 - Method: Adopting the recombinant DNA technology, the prokaryotic expression plasmids of one normal recombinant and tree single-residue variants of bovine prion protein were constructed.
【方法】应用DNA重组技术，正确地构建牛朊蛋白基因的1个正常重组朊蛋白和3个单氨基酸变异体的原核表达载体，经转化E。 - Construction of an Amylolytic and Ethanol-producing Yeast Strain by Recombinant DNA Technology
用基因重组技术构建可降解淀粉和产生酒精的酵母工程菌 - Although we are now able to produce pharmacological peptides by recombinant DNA technology, yet we fail to produce amidated peptides in the same way because bacteria lack the a-amidase.
尽管我们能够通过重组DNA技术利用细菌生产具有药理活性的蛋白质，然而这种技术却不能用于生产酰胺化多肽，因为细菌中没有α-酰胺化酶。